ARUK Dementia Consortium Roadshow
Find out more about how the Dementia Consortium can support you
All posts by Dementia Researcher
How I switched from academia to science communication
Science communication can be a welcome destination for some PhD students, but my road there was not straightforward. It required support from a life coach and international organisations, explains Evguenia Alechine in this blog for Nature Careers.
Time to flip your presentation format
Conference presentations often follow a simple narrative format. Pat Thomson discusses the benefits of adopting a less linear narrative structure and how doing so can create space for discussing the key messages in a research presentation.
Podcast – MSc Programmes in Advanced Dementia Studies
Megan O’Hare talks with Catherine Quinn and Ana Barbosa about MSc programmes in dementia studies, who they suit, and how they can support care and academia too.
Profile – Dr Ana Barbosa
Dementia care consultant and trainer at the Centre for Applied Dementia Studies, University of Bradford with scraped knees and a bag full of records.
Profile – Dr James Pickett
Former Head of Research for Alzheimer’s Society now Hub Development Manager for Health Data Research UK
Profile – Dr Lucy Stirland, The University of Edinburgh
Dr Lucy Stirland is an academic old age psychiatrist at The University of Edinburgh and NHS Lothian studing multimorbidity & dementia
New NIHR Applied Research Collaborations to tackle the biggest challenges faced by the health and care system
The NIHR has announced a £135 million investment in 15 new NIHR Applied Research Collaborations (ARCs).
How to organise a conference that’s open to everyone
Blog by Nic Fleming for Nature Careers, discussing how to ensure your next event is open to everyone.
Profile – Ester Bellavia
PhD candidate at Newcastle University and Registered Nurse, researching dementia care. Enjoys playing Goldylocks, and isn’t afraid of the bears!
Podcast – AAIC 2019 Day Four
Final AAIC 2019 update from Los Angeles as Adam Smith and guests reflect on day four, from biomarkers and risk genes to trials, diversity and future directions.
Profile – Dr Tom Doherty, Eisai
Associate Director, Clinical Development at Eisai working on AD clinical trials from BACE inhibitors to monoclonal antibodies targetting both amyloid and tau.